Clinical characteristics and prognostic value of the <i>KRAS G12C</i> mutation in Chinese non-small cell lung cancer patients.

Biomark Res · 2020 · PMC7318746 · PMID 32607238

Europe PMC DOI

hedged sentences

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significanceP = 0.10so close (0.05 < p ≤ 0.1)

Similarly, although more patients had stage IV disease in the G12C subgroup than in the wildtype subgroup, the difference in their distribution did not reach statistical significance ( P = 0.10).

also in 111,027 other papers

reached borderline significanceno p-value reported

Both the KRAS mutation (HR = 1.30, P = 0.07) and KRAS G12C mutation (HR = 1.47, P = 0.07) reached borderline significance.

also in 370 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.